HIGHLIGHTS
- who: Sergio Fragoso-Saavedra and colleagues from the (UNIVERSITY) have published the research: Open Access, in the Journal: (JOURNAL) of January/30,/2021
- what: The authors aimed to determine if pyridostigmine decreases a composite outcome of invasive mechanical ventilation (IMV) and death in adult patients with severe COVID-19. The authors evaluated the efficacy of pyridostigmine as an adjunct therapy to reduce the incidence of IMV or death in hospitalized adults with severe COVID-19. Following the second DSMB interim analysis, the trial was stopped after the recruitment of 188 participants (94 per group) for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.